Business
NuGen M.D. Launches New InsuJet(TM) Brand Store for Direct Purchasing in The European Union (EU)
Access to Needle-Free Delivery of Medications for Patients with Chronic Illnesses Just Becam...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen M.D. Launches New InsuJet(TM) Brand Store for Direct Purchasing in The European Union (EU)Access to Needle-Free Delivery of Medications for Patients with Chronic Illnesses Just Became EasierTORONTO, ON / ACCESSWIRE / June 7, 2022 / NuGen Medical Devices Inc. (TSX.V:NGMD) (\"NuGen'' or the \"Company\"), a leader in needle-free drug delivery, is pleased to announce the launch of a new online brand store for its InsuJetTM needle-free injection device. The brand store is now live to make InsuJetTM available for purchase in the European Union (EU).The store launched June 1, 2022 at https://shop.insujet.com/NuGen M.D.'s needle-free injection system for self-administered injections is approved by Health Canada, holds a CE Mark and gives access to safe and cost-effective drug delivery for millions of patients who suffer from diabetes or other chronic illnesses.\"As we embark on our journey to make fear-free needle-free injections available for humans and pets with chronic illness, we are opening up this direct-to-consumer platform for immediate and easy access to our technology. This will augment our growing sales channels as we continue to build our distributor network in our target markets with large opportunities.\" said Michael Wright, president & CEO of NuGen M.D.About NuGen Medical DevicesNuGen Medical Devices' principal business is the development and commercialization of innovative needle-free injection devices and systems for the administration of subcutaneous medication.It is developing products using needle-free drug delivery technology in several important fields including, but not limited to, anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, psoriasis as well as DNA and conventional/pediatric vaccines.For More Information visit: www.nugenmd.comTwitter: @NuGenMDLinkedIn: https://www.linkedin.com/company/nugenmd/For further information, please contact:Michael WrightPresident and CEONuGen Medical Devices [email protected](514) 992-9484To arrange a media interview with NuGen M.D. contact:Nelson Hudes Hudes Communications International(905) [email protected] Relations Contact:Kin Communications [email protected](604) 684-6730Twitter: @KinCommNeither TSX Venture Exchange nor ...